drugset / Trial / NCT01783717

Effects of Exenatide on Obesity and/or Diabetes Mellitus Due to Hypothalamic Damage

NCT01783717

Unknown 10 enrolled Huashan Hospital
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to examine the effect of exenatide on body weight and glycemic control in subjects with obesity and/or diabetes mellitus due to hypothalamic damage.

Timeline

Start
2012-12
Primary completion
2015-01
Completion
2015-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Exenatide Peptide 10 ug